Female genital schistosomiasis (FGS) is a chronic and preventable condition caused byĀ theĀ Schistosoma haematobiumāa waterborne parasite found in freshwater sources across many parts of sub-Saharan Africa.
When girls and women are repeatedly exposed to contaminated water and do not receive treatment, the infection can slowly progress over months or years, damaging both the urinary and reproductive systems.Ā
FGS is one of the most overlooked sexual and reproductive health conditions in the region. Today, an estimatedĀ 56 million women and girls are living with FGS, many without a diagnosis, and even fewer with access to care.Ā
FGS occurs when parasite eggs become trapped in the reproductive tissues, causing longterm inflammation and scarring. Girls and women may experience symptoms such as:
Without treatment, the damage can lead to profound andĀ longlastingĀ complications, including:
FGS creates open sores and increases inflammation in the genital tract. This makes it far easier for virusesāincluding HIVāto enter the body. Girls and women living with FGS areĀ up to three times more likelyĀ toĀ acquireĀ HIV compared to their peers. Addressing FGS is therefore not only essential for womenās healthāit is also a critical HIV prevention strategy.
No. FGS isĀ notĀ a sexually transmitted infection.
It develops only after someoneĀ acquiresĀ schistosomiasis throughĀ skin contact with contaminated freshwater. Because symptoms can resemble those of STIs, women may face stigma or be misdiagnosed, often leading to unnecessary treatments and emotional distress.
Diagnosis currently depends on:
However, many health facilities in affected communities lack the equipment and trainingĀ requiredĀ forĀ accurateĀ diagnosis. FGS is not routinely taught in medical programmes, meaning many healthcare workers have never learned to recognise it. As a result, the diseaseĀ remainsĀ under detected, misdiagnosed, and largely untreated.
To support clinicians, the World Health Organization has developed an FGS Pocket Atlas,Ā providingĀ clear visual guidance onĀ identifyingĀ the disease.
FGS can be treated withĀ praziquantel, a safe, inexpensive medicine that kills the parasite and prevents new damage. Treatment can ease symptoms and stop progression. However, once advanced lesions or scarring develop, they cannot be fully reversed. This makes early detection and regular treatment essential.
Ending FGS requires more than clinical toolsāit requires knowledge, training, and systems that put women and girls first.
Raising awareness helps to:
Communities, healthcare systems, and global partners all have a role to play.
Unlimit Health works to ensure that women affected by FGS are no longer invisible. Through our leadership in theĀ FGS Integration Group (FIG)āa coalition of organisations fighting to end this diseaseāwe are advancing coordinated action across:
Together, we are raising awareness, advocating for policy change, and promoting sustainable approaches that bring FGS services to scale. Read our FGS position paper.
We champion the integration of FGS services intoĀ primary healthĀ care, becauseĀ integration means:
Efficiency
Using existing systems, staff, and platformsāmaximising value for money and reducing costs for patients.
Equity
Reaching those who have historically been left behind, including women in rural or underserved communities.
Dignity
Ending years of misdiagnosis, unnecessary procedures, and silent suffering.
Download Unlimit Health’s position on FGS.
An innovative coalition of organisations galvanising joint action to tackle the neglected issue of FGS.
Integrating preventive treatment for FGS into the national health system.
Improving adolescent girlsā and womenās health by reducing morbidity associated with FGS.
24 July 2025
The Ministry of Health (MoH) in Liberia is the first country to develop a National Strategy for female genital schistosomiasis (FGS), leading the way in protecting women and girls from this hidden reproductive health issue.
Full story
9 August 2024
Female genital schistosomiasis (FGS) is seen in national news outlet, the Guardian, highlighting the advocacy work of the FGS Integration Group (FIG), crucial integration efforts in Kenya, and the lived reality for women affected by this painful condition.
7 March 2024
Due to misconceptions and stigmatisation, women living with female genital schistosomiasis are often confronted with additional layers of neglect, putting them at risk of life-changing symptoms. By reading this article, youāre supporting women to be seen.
Sign up to receive updates from us via email. Weāll keep you updated with important news, inspiring stories, the latest research, and opportunities to support our vital network. All fields required.
Weāll never distribute your email address to any third party. You may opt out at any time. View ourĀ privacy policy.
Sign up for our mailing list to stay updated with important news, inspiring stories, the latest research, and opportunities to support our vital work.
We’ll never distribute your email address to any third party. You may opt out at any time. View our privacy policy.